Scientific article

Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: Accumbens more promising than caudate

Published inEuropean Neuropsychopharmacology, vol. 24, no. 8, p. 1229-1239
Publication date2014

High-frequency deep brain stimulation (DBS) represents a major stake for treatment for treatment-resistant depression (TRD). We describe a preliminary trial of DBS of two potential brain targets in chronic TRD: the nucleus accumbens (Acb) and, in the event of failure, the caudate nucleus. Patients were followed for 6 months before surgery (M0). From M1 to M5, they underwent stimulation of the Acb target. PET scans allowed us to track metabolic modifications resulting from this stimulation. The caudate target of nonresponders was stimulated between M5 and M9. Patients then entered an extension phase, in which it was possible to adapt stimulation parameters and treatments. Six patients were included and four were operated on. At M5, none of the patients were either responders or remitters, but we did observe a decrease in Hamilton Depression Rating Scale (HDRS) scores. Three patients were switched to caudate stimulation, but no improvement was observed. During the extension phase, the Acb target was stimulated for all patients, three of whom exhibited a significant response. A decrease in glucose metabolism was observed after Acb stimulation, in the posterior cingulate gyrus, left frontal lobe, superior and medial gyrus, and bilateral cerebellum. An increase in metabolism was observed in the bilateral frontal lobe (superior gyrus), left frontal lobe (medial gyrus), and right limbic lobe (anterior cingulate gyrus). The results of this trial suggest that Acb is a more promising target than the caudate. NCT01569711.

  • Deep brain stimulation
  • Accumbens
  • Caudate
  • Treatment-resistant depression
  • Therapeutic trial
Citation (ISO format)
MILLET, Bruno et al. Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: Accumbens more promising than caudate. In: European Neuropsychopharmacology, 2014, vol. 24, n° 8, p. 1229–1239. doi: 10.1016/j.euroneuro.2014.05.006
Main files (1)
Article (Published version)
ISSN of the journal0924-977X

Technical informations

Creation04/18/2018 9:33:00 AM
First validation04/18/2018 9:33:00 AM
Update time03/15/2023 8:09:23 AM
Status update03/15/2023 8:09:22 AM
Last indexation10/19/2023 8:13:09 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack